IBEROGAST
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for IBEROGAST, covering 2018-04-24 to 2018-10-29. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy/Safety Study to Confirm Iberogast's Efficacy in Patients With Irritable Bowel Syndrome Diagnosed on ROME III Criteria Compared to Placebo [Phase 3]